Non Clear Cell Renal Cell Carcinoma (nccRCC)
1 competing product in clinical development for Non Clear Cell Renal Cell Carcinoma (nccRCC).
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| lenvatinib + everolimus | Eisai | Phase 2 | Completed | 35 |